Gastric cancer

CTD - Clinical Trials Data

Abbreviations

DESTINY-Gastric01
TRASDRX vs irin / pacl
L3

details

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
First author: K. Shitara

Link

NCT03329690

ToGA
TRAS+chemo vs chemo
L1

details

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer
First author: Yung-Jue Bang

Link

NCT01041404